Photo from wikipedia
Prostate cancer (pCa) is the second most common non-cutaneous malignant neoplasm in men worldwide, with an estimated incidence of 1.1 million new cases per year. Furthermore, it is the fifth… Click to show full abstract
Prostate cancer (pCa) is the second most common non-cutaneous malignant neoplasm in men worldwide, with an estimated incidence of 1.1 million new cases per year. Furthermore, it is the fifth leading cause of cancer-related death, representing 6.6% of total male mortality (1).
Keywords:
immunotherapy castration;
effective combinatorial;
prostate cancer;
combinatorial immunotherapy;
cancer
Journal Title: Translational cancer research
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Translational cancer research
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!